Pays: Royaume-Uni
Langue: anglais
Source: MHRA (Medicines & Healthcare Products Regulatory Agency)
Ciprofloxacin hydrochloride
Bayer Plc
J01MA02
Ciprofloxacin hydrochloride
750mg
Oral tablet
Oral
No Controlled Drug Status
Valid as a prescribable product
BNF: 05011200; GTIN: 5010605050114
029_0 Page 1 of 10 Due to regulatory changes, the content of the following Patient Information Leaflet may vary from the one found in your medicine pack. Please compare the 'Leaflet prepared/revised date' towards the end of the leaflet to establish if there have been any changes. If you have any doubts or queries about your medication, please contact your doctor or pharmacist. PACKAGE LEAFLET: INFORMATION FOR THE PATIENT CIPROXIN 750MG FILM-COATED TABLETS Ciprofloxacin READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. Keep this leaflet. You may need to read it again. If you have any further questions, ask your doctor or pharmacist. This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET 1. What Ciproxin is and what it is used for 2. What you need to know before you take Ciproxin 3. How to take Ciproxin 4. Possible side effects 5. How to store Ciproxin 6. Contents of the pack and other information 1. WHAT CIPROXIN IS AND WHAT IT IS USED FOR Ciproxin contains the active substance ciprofloxacin. Ciprofloxacin is an antibiotic belonging to the fluoroquinolone family. Ciprofloxacin works by killing bacteria that cause infections. It only works with specific strains of bacteria. Adults Ciproxin is used in adults to treat the following bacterial infections: 029_0 Page 2 of 10 respiratory tract infections long lasting or recurring ear or sinus infections urinary tract infections genital tract infections in men and women gastro-intestinal tract infections and intra-abdominal infections skin and soft tissue infections bone and joint infections to prevent infections due to the bacterium _Neisseria meningitidis_ anthrax inhalation exposure Ci Lire le document complet
OBJECT 1 CIPROXIN TABLETS 750MG Summary of Product Characteristics Updated 28-Sep-2017 | Bayer plc 1. Name of the medicinal product Ciproxin 750 mg film-coated tablets 2. Qualitative and quantitative composition Each film-coated tablet contains 750 mg ciprofloxacin (as hydrochloride). For the full list of excipients, see section 6.1. 3. Pharmaceutical form Film-coated tablet. Oblong, nearly white to slightly yellowish tablets marked with CIP 750 on one side and BAYER on the reverse side. 4. Clinical particulars 4.1 Therapeutic indications Ciproxin 750 mg film-coated tablets are indicated for the treatment of the following infections (see sections 4.4 and 5.1). Special attention should be paid to available information on resistance to ciprofloxacin before commencing therapy. Consideration should be given to official guidance on the appropriate use of antibacterial agents. Adults • Lower respiratory tract infections due to Gram-negative bacteria - exacerbations of chronic obstructive pulmonary disease - broncho-pulmonary infections in cystic fibrosis or in bronchiectasis - pneumonia • Chronic suppurative otitis media • Acute exacerbation of chronic sinusitis especially if these are caused by Gram-negative bacteria • Urinary tract infections • Genital tract infections - gonococcal uretritis and cervicitis due to susceptible _Neisseria gonorrhoeae_ - epididymo-orchitis including cases due to susceptible _Neisseria gonorrhoeae_ - pelvic inflammatory disease including cases due to susceptible _Neisseria gonorrhoeae_ • Infections of the gastro-intestinal tract (e.g. travellers' diarrhoea) • Intra-abdominal infections • Infections of the skin and soft tissue caused by Gram-negative bacteria • Malignant external otitis • Infections of the bones and joints • Prophylaxis of invasive infections due to _Neisseria meningitidis_ • Inhalation anthrax (post-exposure prophylaxis and curative treatment) Ciprofloxacin may be used in the management of neutropenic patients with fever that is suspected t Lire le document complet